provider and developer of advanced personal telemedicine solutions, today announced that it
distributed on September 23, 2011 to its shareholders a cash dividend in the amount of USD
66 cents per share, totaling approximately USD 7 million.
The total dividend amount distributed to each shareholder amounts to 80% of the dividend
amount with 20% taxes withheld and deposited with a trustee on September 23, 2011 for a
90 day period, after which they will be transferred to the Israeli Tax Authorities.
For the convenience of SHL’s shareholders, Ernst & Young, Israel, together with a trustee
have been hired by SHL in order to facilitate claiming back, in whole or in part, the taxes
withheld.
Each shareholder is invited to contact Mr. Zami Flitter of Ernst & Young, Israel (see contact
info. below) within the said 90 days (but not later than such period) in order to file for his
withholding return. Ernst & Young, at its sole discretion, based on the documents presented
to it per its request and the relevant tax laws and tax treaties, shall instruct the trustee
whether to release any, part or all of the taxes withheld to the shareholder or to the Israeli tax
authorities as the case may be (together with a pro rata interest accrued thereon, if any)
during and after the 90 day period. Withholding returns to shareholders will be made in NIS,
unless a shareholder requests from Ernst &Young that payment shall be made in USD,
which in that case the withheld NIS amount shall be converted to USD, based on the
applicable exchange rate at such date.
Ernst & Young, Israel
Mr. Zami Flitter
Phone: 972-3-5687488
Fax: 972-3-5621484
Email: [email protected]
About SHL Telemedicine
SHL Telemedicine Ltd. specializes in developing and marketing advanced personal telemedi-
cine systems as well as providing comprehensive telemedicine solutions including medical
call centers to individuals and to the healthcare community. As a leading provider of remote
health services in cardiology and in other medical areas, SHL maintains business operations
in Europe, mainly in Germany, and at its home market in Israel. In the US, certain SHL
telemedicine products are distributed by Philips Healthcare. SHL is listed on the SIX Swiss
Exchange (SHLTN, ISIN: IL0010855885, Security No.: 1128957). More information available
at: www.shl-telemedicine.com.
For further information please contact:
- Erez Alroy, Co-CEO, Phone: +972 3561 22 12, [email protected]
- Assistant: Pauline Shavit, Phone: +972 3561 22 12, [email protected]
- Martin Meier-Pfister, IRF Communications, Phone: +41 43 244 81 40, [email protected]
Some of the information contained in this press release contains forward-looking statements. Readers
are cautioned that any such forward-looking statements are not guarantees of future performance and
involve risks and uncertainties, and that actual results may differ materially from those in the forward looking statements as a result of various factors. SHL Telemedicine undertakes no obligation to
publicly update or revise any forward-looking statements.
